MAPK8 and Alzheimer disease: Gene expression analysis showed that the expression of MAPK8, CTNNB1, NFKB1, EGFR, CXCL8, CCL2, BCL2, and NFE2L2 increased or decreased in the hippocampus of patients with AD.